رجوع
41
57
نطاق اليوم
KWD 0.20
KWD 0.50
نطاق 52 أسبوعًا
KWD 0.20
KWD 0.50
حجم التداول
1,323
متوسط 50 يوم / 200 يوم
KWD 0.29
/
KWD 0.28
الإغلاق السابق
KWD 0.29
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Healthcare (627 نظير)
| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | 2.8 | 0.3 |
| P/B | 0.1 | 2.9 |
| ROE % | 2.8 | 3.7 |
| Net Margin % | 10.1 | 3.8 |
| Rev Growth 5Y % | 18.5 | 10.0 |
| D/E | 0.3 | 0.2 |
السعر المستهدف للمحللين
لا تتوفر تغطية محللين
تقديرات الأرباح
| الفترة | تقدير ربحية السهم | تقدير الإيرادات | المحللون |
|---|---|---|---|
| FY2028 |
KWD 0.158
KWD 0.149 – KWD 0.166
|
3.8 B | 1 |
| FY2027 |
KWD 0.112
KWD 0.105 – KWD 0.117
|
3.2 B | 1 |
| FY2026 |
KWD 0.089
KWD 0.083 – KWD 0.093
|
2.9 B | 1 |
النقاط الرئيسية
Revenue grew 18.50% annually over 5 years — strong growth
Earnings declined -17.88% over the past year
ROE of 2.78% is below average
Debt/Equity of 0.25 — conservative balance sheet
Generating 366.84M in free cash flow
P/E of 2.76 — trading at a low valuation
النمو
Revenue Growth (5Y)
18.50%
Revenue (1Y)0.81%
Earnings (1Y)-17.88%
FCF Growth (3Y)N/A
الجودة
Return on Equity
2.78%
ROIC2.64%
Net Margin10.07%
Op. Margin16.14%
الأمان
Debt / Equity
0.25
Current Ratio0.51
Interest Coverage7.91
التقييم
P/E Ratio
2.76
P/B Ratio0.08
EV/EBITDA6.26
Dividend Yield0.03%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 0.81% | Revenue Growth (3Y) | 9.05% |
| Earnings Growth (1Y) | -17.88% | Earnings Growth (3Y) | 52.88% |
| Revenue Growth (5Y) | 18.50% | Earnings Growth (5Y) | 2.99% |
| Profitability | |||
| Revenue (TTM) | 2.81B | Net Income (TTM) | 283.10M |
| ROE | 2.78% | ROA | 1.89% |
| Gross Margin | 39.10% | Operating Margin | 16.14% |
| Net Margin | 10.07% | Free Cash Flow (TTM) | 366.84M |
| ROIC | 2.64% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.25 | Current Ratio | 0.51 |
| Interest Coverage | 7.91 | Dividend Yield | 0.03% |
| Valuation | |||
| P/E Ratio | 2.76 | P/B Ratio | 0.08 |
| P/S Ratio | 0.28 | PEG Ratio | -1.26 |
| EV/EBITDA | 6.26 | Dividend Yield | 0.03% |
| Market Cap | 782.54M | Enterprise Value | 2.84B |
Income Statement
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 2.81B | 2.79B | 2.36B | 1.84B | 1.43B |
| Net Income | 283.10M | 344.72M | 121.12M | 339.90M | 251.62M |
| EPS (Diluted) | 0.10 | 0.12 | 0.05 | 0.14 | 0.10 |
| Gross Profit | 1.10B | 1.18B | 913.13M | 771.48M | 565.78M |
| Operating Income | 453.92M | 480.47M | 285.37M | 371.39M | 237.68M |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 14.98B | 14.90B | 15.23B | 12.83B | 9.16B |
| Total Liabilities | 4.63B | 4.71B | 6.50B | 4.07B | 1.70B |
| Shareholders' Equity | 10.27B | 10.09B | 8.64B | 8.55B | 7.28B |
| Total Debt | 2.60B | 2.55B | 4.16B | 2.09B | 406.87M |
| Cash & Equivalents | 546.20M | 624.28M | 1.33B | 862.33M | 681.62M |
| Current Assets | 1.09B | 1.34B | 1.90B | 2.54B | 2.65B |
| Current Liabilities | 2.12B | 1.69B | 2.76B | 1.07B | 555.08M |
درجات الاستراتيجيات
This stock passed the criteria for 2 strategies
Score = fit strength (0–100)
Rank = position among all matches
#424 of 827
#88 of 709
النشاط الأخير
دخل
Deep Value Investing (Seth Klarman)
Mar 24, 2026
دخل
Defensive Investing (Benjamin Graham)
Mar 24, 2026